Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Ronina Covar

Concepts (260)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
77
2023
2212
5.730
Why?
Anti-Asthmatic Agents
29
2021
371
3.150
Why?
Bronchial Provocation Tests
6
2022
50
1.650
Why?
Bronchodilator Agents
15
2019
243
1.550
Why?
Adrenal Cortex Hormones
15
2022
518
1.500
Why?
Respiratory Sounds
12
2022
120
1.290
Why?
Budesonide
9
2016
88
1.150
Why?
Bronchial Hyperreactivity
5
2018
104
1.090
Why?
Eosinophilia
2
2023
204
0.860
Why?
Nedocromil
5
2016
32
0.830
Why?
Albuterol
10
2018
103
0.830
Why?
Administration, Inhalation
22
2022
661
0.810
Why?
Glucocorticoids
11
2019
572
0.810
Why?
Androstadienes
7
2016
106
0.800
Why?
Fluticasone
10
2019
90
0.790
Why?
Lung
8
2022
3745
0.790
Why?
Respiratory Function Tests
13
2018
580
0.780
Why?
Forced Expiratory Volume
16
2022
509
0.680
Why?
Respiratory Mechanics
1
2020
63
0.650
Why?
Anti-Inflammatory Agents
10
2016
467
0.640
Why?
Leukotriene Antagonists
6
2016
43
0.620
Why?
Mediastinal Emphysema
1
2018
6
0.590
Why?
Nitric Oxide
6
2023
881
0.560
Why?
Child
49
2023
20636
0.520
Why?
Acetates
7
2014
96
0.490
Why?
Double-Blind Method
19
2021
1852
0.480
Why?
Quinolines
7
2014
154
0.470
Why?
Marijuana Smoking
1
2018
239
0.460
Why?
Eosinophils
6
2023
323
0.440
Why?
Child, Preschool
35
2022
10378
0.420
Why?
Precision Medicine
4
2021
384
0.420
Why?
Humans
85
2023
128019
0.420
Why?
Sputum
4
2023
301
0.410
Why?
Adrenergic beta-Agonists
4
2013
130
0.390
Why?
Cannabis
1
2018
426
0.360
Why?
Phenotype
4
2020
3039
0.350
Why?
Biomarkers
10
2023
3874
0.340
Why?
Eicosapentaenoic Acid
1
2010
36
0.340
Why?
Docosahexaenoic Acids
1
2010
83
0.330
Why?
Randomized Controlled Trials as Topic
6
2021
1356
0.330
Why?
Salmeterol Xinafoate
6
2019
41
0.330
Why?
Adolescent
31
2022
20158
0.320
Why?
Male
53
2020
62757
0.310
Why?
Ibuprofen
2
2021
80
0.300
Why?
Spirometry
9
2022
252
0.280
Why?
Female
52
2020
68016
0.280
Why?
Drug Therapy, Combination
7
2016
1012
0.270
Why?
Antioxidants
1
2010
542
0.270
Why?
Breath Tests
3
2023
89
0.260
Why?
Treatment Outcome
15
2019
10110
0.250
Why?
Disease Progression
9
2018
2598
0.250
Why?
Pulmonary Disease, Chronic Obstructive
2
2022
944
0.230
Why?
Pulmonary Ventilation
1
2005
77
0.230
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2005
198
0.220
Why?
Microbiota
2
2023
719
0.210
Why?
Severity of Illness Index
12
2021
2703
0.210
Why?
Beclomethasone
2
2015
27
0.210
Why?
Ribonucleases
1
2003
54
0.210
Why?
Mycobiome
1
2023
9
0.210
Why?
Adrenergic beta-Antagonists
1
2005
319
0.200
Why?
Larynx
1
2023
55
0.200
Why?
Prospective Studies
8
2023
7035
0.200
Why?
Respiration
1
2003
190
0.200
Why?
Antigens, Dermatophagoides
1
2022
10
0.190
Why?
Muscarinic Antagonists
1
2022
25
0.190
Why?
Dietary Supplements
2
2020
531
0.190
Why?
Airway Obstruction
2
2022
149
0.190
Why?
Azithromycin
2
2015
91
0.190
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2005
332
0.190
Why?
Prednisone
4
2016
230
0.190
Why?
Models, Biological
1
2008
1689
0.180
Why?
Vitamin D Deficiency
2
2020
176
0.170
Why?
Infant
15
2022
8912
0.170
Why?
Cholecalciferol
1
2020
56
0.170
Why?
Leukocyte Count
4
2019
325
0.170
Why?
Methacholine Chloride
3
2022
51
0.170
Why?
Cross-Over Studies
6
2019
507
0.160
Why?
Mometasone Furoate
1
2019
5
0.160
Why?
Adrenergic beta-2 Receptor Agonists
1
2019
35
0.160
Why?
Tiotropium Bromide
1
2019
19
0.160
Why?
Vitamins
1
2020
174
0.160
Why?
Symbiosis
1
2019
71
0.160
Why?
Minority Groups
1
2021
250
0.150
Why?
Social Class
1
2021
258
0.150
Why?
Risk Factors
8
2016
9696
0.150
Why?
Population
1
2018
33
0.150
Why?
Cyclopropanes
7
2014
88
0.150
Why?
Acetaminophen
2
2021
245
0.150
Why?
Education
1
2018
100
0.140
Why?
Sulfides
7
2014
94
0.140
Why?
Practice Guidelines as Topic
2
2021
1482
0.140
Why?
Patient Selection
1
2021
658
0.140
Why?
Airway Remodeling
1
2016
58
0.130
Why?
Benzyl Alcohols
1
2016
2
0.130
Why?
Chlorobenzenes
1
2016
9
0.130
Why?
Child Care
1
2016
26
0.130
Why?
Adult
13
2023
35176
0.130
Why?
Eczema
2
2014
67
0.130
Why?
Tomography, X-Ray Computed
3
2021
2509
0.130
Why?
Anti-Bacterial Agents
3
2015
1689
0.120
Why?
Genetic Predisposition to Disease
3
2016
2261
0.120
Why?
Dose-Response Relationship, Drug
6
2019
1943
0.120
Why?
Bronchoconstrictor Agents
2
2006
16
0.120
Why?
Cluster Analysis
1
2016
477
0.110
Why?
Secondary Prevention
1
2015
217
0.110
Why?
Lectins
1
2014
46
0.110
Why?
Drug Administration Schedule
5
2016
755
0.110
Why?
Adipokines
1
2014
47
0.110
Why?
Clinical Decision-Making
1
2016
302
0.110
Why?
Teaching
1
2016
210
0.110
Why?
Obesity
2
2017
2859
0.110
Why?
Prognosis
2
2016
3766
0.110
Why?
Food Hypersensitivity
1
2016
173
0.100
Why?
Drug-Related Side Effects and Adverse Reactions
1
2016
251
0.100
Why?
Overweight
1
2017
522
0.100
Why?
Reproducibility of Results
1
2021
3009
0.100
Why?
Virus Diseases
1
2015
209
0.100
Why?
Body Height
2
2011
192
0.100
Why?
Age Factors
3
2016
3100
0.100
Why?
Disease Management
1
2016
583
0.100
Why?
Patient Acceptance of Health Care
1
2018
756
0.100
Why?
Clinical Trials as Topic
1
2016
997
0.100
Why?
Adaptive Clinical Trials as Topic
2
2021
20
0.090
Why?
Genomics
1
2016
714
0.090
Why?
Multicenter Studies as Topic
2
2018
285
0.090
Why?
Recurrence
3
2016
993
0.090
Why?
Respiratory Tract Infections
1
2015
372
0.090
Why?
Schools
2
2018
436
0.090
Why?
Dexamethasone
2
2005
339
0.090
Why?
Immunoglobulin E
3
2015
329
0.090
Why?
Young Adult
4
2022
12281
0.090
Why?
Symptom Flare Up
2
2020
38
0.090
Why?
Vital Capacity
3
2022
289
0.080
Why?
Longitudinal Studies
3
2016
2706
0.080
Why?
Research Design
3
2021
1034
0.080
Why?
Skin Tests
2
2015
100
0.080
Why?
Time Factors
3
2008
6479
0.080
Why?
Drug Synergism
2
2008
356
0.080
Why?
Growth
2
2018
58
0.080
Why?
Caregivers
1
2016
810
0.080
Why?
Kaplan-Meier Estimate
3
2016
851
0.070
Why?
Immunotherapy
1
2012
586
0.070
Why?
Hypersensitivity
2
2018
249
0.070
Why?
Health Knowledge, Attitudes, Practice
1
2016
1272
0.070
Why?
Adenosine Monophosphate
1
2007
62
0.070
Why?
Respiratory Tract Diseases
1
2008
148
0.070
Why?
Inflammation
4
2005
2646
0.070
Why?
Drug Resistance
2
2018
165
0.070
Why?
School Health Services
1
2009
232
0.060
Why?
Cohort Studies
3
2011
5378
0.060
Why?
Drug Combinations
2
2019
323
0.060
Why?
Regression Analysis
1
2008
978
0.060
Why?
Weight Gain
1
2009
503
0.060
Why?
Treatment Failure
2
2020
338
0.060
Why?
Incidence
2
2016
2614
0.060
Why?
Administration, Oral
3
2013
766
0.060
Why?
Multivariate Analysis
1
2008
1492
0.060
Why?
Bone Density
1
2008
474
0.060
Why?
Biopsy
2
2005
1077
0.060
Why?
Lymphocyte Activation
2
2005
1096
0.050
Why?
Eosinophil Granule Proteins
1
2003
21
0.050
Why?
Cross-Sectional Studies
5
2015
5034
0.050
Why?
Logistic Models
2
2010
1975
0.050
Why?
Global Health
1
2006
327
0.050
Why?
Age of Onset
3
2014
490
0.050
Why?
Age Distribution
1
2004
369
0.050
Why?
Sex Distribution
1
2004
356
0.050
Why?
Health Status
1
2008
747
0.050
Why?
Statistics, Nonparametric
1
2003
419
0.050
Why?
Health Services Accessibility
1
2009
895
0.050
Why?
Research
2
2022
408
0.050
Why?
Clarithromycin
1
2001
28
0.050
Why?
Environmental Exposure
1
2006
458
0.050
Why?
Bronchi
1
2003
241
0.050
Why?
Clinical Trials, Phase II as Topic
1
2021
72
0.050
Why?
Fungi
1
2023
136
0.050
Why?
Trachea
1
2023
221
0.050
Why?
Blood Proteins
1
2003
239
0.050
Why?
Cushing Syndrome
1
2000
10
0.040
Why?
Diagnosis, Differential
1
2005
1408
0.040
Why?
Dyspnea
1
2022
238
0.040
Why?
Adrenal Glands
1
2000
70
0.040
Why?
Clinical Protocols
1
2021
253
0.040
Why?
Geography
1
2021
186
0.040
Why?
Advisory Committees
1
2021
214
0.040
Why?
Moraxella
1
2019
5
0.040
Why?
Carnobacteriaceae
1
2019
3
0.040
Why?
Medication Adherence
2
2019
559
0.040
Why?
Streptococcus
1
2019
25
0.040
Why?
Staphylococcus
1
2019
74
0.040
Why?
Exercise Test
1
2022
613
0.040
Why?
Nasal Mucosa
1
2019
107
0.040
Why?
Allergens
1
2022
381
0.040
Why?
Animals
2
2022
34487
0.040
Why?
Middle Aged
6
2019
30812
0.040
Why?
Peak Expiratory Flow Rate
1
2018
36
0.040
Why?
Prevalence
1
2005
2541
0.040
Why?
Absenteeism
1
2018
47
0.040
Why?
United States
3
2021
13785
0.040
Why?
Vitamin D
1
2020
380
0.030
Why?
Netherlands
1
2016
77
0.030
Why?
Sex Factors
2
2016
1942
0.030
Why?
T-Lymphocytes
1
2005
1921
0.030
Why?
Bacteria
1
2023
812
0.030
Why?
Pharmacokinetics
1
2016
24
0.030
Why?
Airway Resistance
2
2006
38
0.030
Why?
Placebo Effect
1
2016
55
0.030
Why?
Plethysmography
2
2006
106
0.030
Why?
Exhalation
1
2015
38
0.030
Why?
Fever
1
2016
295
0.030
Why?
Anaphylaxis
1
2016
98
0.030
Why?
Drug Resistance, Bacterial
1
2015
170
0.030
Why?
Chitinase-3-Like Protein 1
1
2014
19
0.030
Why?
Fluticasone-Salmeterol Drug Combination
1
2014
12
0.030
Why?
Needs Assessment
1
2016
356
0.030
Why?
Leukotriene E4
1
2013
25
0.030
Why?
Combined Modality Therapy
1
2016
1199
0.030
Why?
Morbidity
1
2014
301
0.030
Why?
Drug Monitoring
1
2014
190
0.030
Why?
Acute Disease
1
2015
961
0.020
Why?
Polymerase Chain Reaction
1
2015
1020
0.020
Why?
Colorado
2
2014
4369
0.020
Why?
Prednisolone
1
2011
82
0.020
Why?
Hypertension
1
2000
1234
0.020
Why?
Pain
1
2016
748
0.020
Why?
Genome-Wide Association Study
1
2016
1330
0.020
Why?
Curriculum
1
2016
909
0.020
Why?
Body Mass Index
1
2017
2260
0.020
Why?
Polymorphism, Single Nucleotide
1
2016
2059
0.020
Why?
Poverty
1
2012
497
0.020
Why?
Eosinophil Cationic Protein
1
2008
10
0.020
Why?
Bone Diseases, Metabolic
1
2008
59
0.020
Why?
Follow-Up Studies
1
2016
4853
0.020
Why?
Factor Analysis, Statistical
1
2008
283
0.020
Why?
Body Weight
1
2011
930
0.020
Why?
Insurance, Health
1
2009
267
0.020
Why?
Retrospective Studies
3
2014
14404
0.020
Why?
Lung Volume Measurements
1
2006
43
0.020
Why?
Birth Weight
1
2009
499
0.020
Why?
Oscillometry
1
2006
37
0.020
Why?
Biomedical Research
1
2012
632
0.020
Why?
Inhibitory Concentration 50
1
2005
82
0.010
Why?
Respiratory Hypersensitivity
1
2005
64
0.010
Why?
Predictive Value of Tests
1
2009
1934
0.010
Why?
Diabetes Mellitus, Type 1
1
2000
3625
0.010
Why?
Basement Membrane
1
2003
30
0.010
Why?
Reference Values
1
2005
776
0.010
Why?
Interleukins
1
2005
240
0.010
Why?
In Vitro Techniques
1
2005
1047
0.010
Why?
Fractures, Bone
1
2008
393
0.010
Why?
Immune Tolerance
1
2005
347
0.010
Why?
Muscle, Smooth
1
2003
152
0.010
Why?
Bronchoscopy
1
2003
208
0.010
Why?
Steroids
1
2002
147
0.010
Why?
Sensitivity and Specificity
1
2005
1813
0.010
Why?
Gene Expression
1
2005
1454
0.010
Why?
RNA, Messenger
1
2005
2669
0.010
Why?
Surveys and Questionnaires
1
2009
5353
0.010
Why?
Pilot Projects
1
2001
1559
0.010
Why?
Aged
2
2005
21892
0.010
Why?
Covar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)